Table 4.
Components | Agent/Intervention | Study Phase | Clinicaltrials.gov Identifier | Study Status | Type/Stage of Breast Cancer |
---|---|---|---|---|---|
Vascular Endothelial Growth Factor (VEGF) | Bevacizumab | II | NCT00016549 | Completed | Breast Cancer |
NCT01190345 | Completed | ||||
Bevacizumab with Herceptin | I/II | NCT00095706 | Completed | Breast Cancer |